Abstract: Subcorneal pustular dermatosis is a rare pustular eruption which occurs mainly in middle-aged women and rarely during childhood. We report a case of a 15-year-old female with a 4-year history of pustular lesions on the proximal region of the upper limbs with subsequent impairment of the trunk. Physical examination revealed small pustules distributed on the trunk and proximal region of the limbs. Histopathology showed a subcorneal pustule and direct immunofluorescence for IgA, IgM, IgG and fibrinogen was negative, confirming the diagnosis of subcorneal pustular dermatosis. The patient was treated with dapsone with good clinical response after one month. Subcorneal pustular dermatosis is a rare condition and there are only isolated cases reported in the literature in pediatric patients. Thus, we discuss the main clinical aspects and treatment response of this condition during childhood.
INTRODUCTION
Subcorneal pustular dermatosis (SPD), also known as Sneddon-Wilkinson´s disease, is a rare, chronic, relapsing pustular eruption. 1 It is clinically relevant given its association with malignant neoplasms such as multiple myeloma, chronic lymphocytic leukemia and thymoma. 2 This condition is more common in women over 40 years of age and few cases have been reported in children. 3 We report a case of a teenager diagnosed with SPD.
CASE REPORT
A 15-year-old female patient presented with a 4-year history of pustular lesions on the proximal region of the upper limbs with a subsequent impairment of the chest and abdomen. During this period, the lesions showed temporary episodes of improvement that evolved with residual hyperchromic macules. After treatment was instituted we observed a slight increase of total bilirubin (TB = 1.7, DB = 1.2) and a slight decrease of hemoglobin (Hb = 10.7). There were no alterations on the remaining markers of hemolysis and on G6PD dosage. We chose to maintain the treatment and throughout the patient's follow-up all laboratory results remained stable. After complete clinical improvement, dapsone was tapered to 50mg/day and the patient was followed-up every three months. Nine months after treatment was started no flares had been noticed.
eruption for three weeks and described it as "half-and-half", indicating that the lower half of the lesion presented a sterile purulent content and the upper half a serous one, which is characteristic of the disease. 1 There are less than 20 cases of pediatric SPD described in the literature. 
